Mifeprex, a progesterone blocker used to end a pregnancy that is less than 10 weeks along.
It’s been a record year for anti-abortion laws introduced in state legislatures, and in Louisiana, the latest battle is over a procedure not backed by scientific consensus and that could potentially harm women.
Abortions are common in Louisiana, where about 8,000 are performed every year. Medication abortions, in which women take pills rather than undergo a surgical procedure, make up two of every five abortions in the state.
They’re deemed safe and effective by the U.S. Food and Drug Administration (FDA) and the American College of Obstetricians and Gynecologists (ACOG).
May 27, 2021 3:34 pm
Marie Claire is supported by its audience. When you purchase through links on our site, we may earn commission on some of the items you choose to buy.
FYI, it s actually super common.
If you’re searching the web trying to find out why your vagina burns after sex, public service announcement: a bit like sex dreams, chafing during the summer months and UTI’s, it’s actually quite common.
It might not be a hot topic of conversation between you and your mates, sure, but it happens to most women at some point in their lifetime.
An American College of Obstetrics and Gynae survey found that around 75% of women will feel pain during sex, and one of those pains is a burning or stinging discomfort either during or after.
Lifting FDA restrictions on mifepristone could normalize medication abortion
In a new study published online in spring 2021 and in the July issue of the journal
Contraception, University of Chicago Medicine investigators and colleagues interviewed primary care providers in Illinois about their interest in providing medication abortion care and found that lifting FDA restrictions on mifepristone to allow pharmacy dispensing could normalize medication abortion, facilitate its use in primary care facilities, and address disparities in reproductive health access. Mifepristone is used in combination with misoprostol to end early pregnancies, during the first trimester, said senior author Debra Stulberg, MD, MAPP, Chair of the Department of Family Medicine at the UChicago Medicine. The two-drug regimen is safe and highly effective, but access is limited by a strict Risk Evaluation and Mitigation Strategy (REMS) that prohibits pharmacy dispensing of mifepristone.